Is it possible to prevent rheumatic fever?

Indian Heart Journal

Volumn 56, Issue 6, 2004, Pages 677-679

  Tandon, R ^a  

^a SITARAM BHARTIA INSTITUTE OF SCIENCE AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; PNEUMOCOCCUS VACCINE; PROCAINE PENICILLIN; STREPTOCOCCUS VACCINE;

PRIMARY PREVENTION; PRIMORDIAL PREVENTION; PROPHYLAXIS; RHEUMATIC FEVER; SECONDARY PREVENTION; SHORT SURVEY; SORE THROAT; STREPTOCOCCUS INFECTION; VACCINATION;

BACTERIAL VACCINES; HUMANS; INDIA; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE;

EID: 14144250186     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994; 124: 9-16
2. Congeni B, Rizzo C, Congeni J, Sreenivasan VV. Outbreak of acute rheumatic fever in northeast Ohio. J Pediatr 1987; 111: 176-179
3. Hosier DM, Craenen JM, Teske DW, Wheller JJ. Resurgence of acute rheumatic fever. Am J Dis Child 1987; 141: 730-733
4. Veasy LG. Lessons learned from the resurgence of rheumatic fever in the united States. In: Narula J, Virmani R, Reddy KS, Tandon R (eds). Rheumatic Fever. Washington: Am Registry of Path 1999, pp 69-78
5. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular disease in the Young, the American Heart Association. Pediatrics 1995; 96: 758-764
6. Juneja R, Tandon R. Rheumatic carditis: a reappraisal. Indian Heart J 2004; 56: 252-255
7. Krishnakumar R, Rammohan R, Narula J, Kaplan EL. Epidemiology of streptococcal pharyngitis, rheumatic fever and rheumatic heart disease. In: Narula J, Virmani R, Reddy KS, Tandon R (eds). Rheumatic Fever. Washington: Am Registry of Path: 1999, p 60
8. Fischetti VA. Vaccine development for Group A streptococcal Infection. In: Narula J, Virmani R, Reddy KS, Tandon R (eds). Rheumatic Fever. Washington: Am Registry of Path: 1999, pp 473-484
9. Kaplan EL, Wotton JT, Johnson DR. Dynamic epidemiology of group A streptococcus serotypes associated with pharyngitis. Lancet 2001; 358: 1334-1337
10. Bennett-Wood V, Selvaraj G, Goodfellow A, Martin D, Sriprakash KS, Robins-Browne R, et al. Highly virulent group A streptococci that appear not to express M protein. (Abstract 05.6) Presented at the XV Lancefield International Symposium on Streptococci and Streptococcal Diseases. Goa, India, Oct 2002
11. McMillan DJ, Davies MR, Browning CL, Good MF, Sriprakash KS. Prospecting for new group A streptococcal vaccine candidates. Indian J Med Res 2004; 119 (Suppl): 121-125
12. Gulizia JM, McManus BM. Immuno-pathological studies of rheumatic fever. In: Narula J, Virmani R, Reddy KS, Tandon R (eds). Rheumatic Fever. Washington: Am Registry of Path: 1999, pp 235-244